Study online at https://quizlet.com/_dj82r4
1. WHICH OF THESE DOES NOT RESULT IN SPINAL CORD COMPRES-
THE FALSELY ELEVATED BONE MINERAL SION
DENSITY OF THE SPINE DURING DXA?
1. SPINAL CORD COMPRESSION
2. COMPRESSION FRACTURES
3. SEVERE SCOLIOSIS
4. OSTEOPHYTOSIS
2. BONE REMODELING CYLCE 1. ACTIVATION
2. RESORPTION
3. REVERSAL
4. FORMATION
3. ROMOSOZUMAB AQQP (EVENITY) -stimulates osteoblastic for-
mation
-injection/2 injections once
monthly for 12 months
4. List of Sclerostin Inhibitors ROMOSOZUMAB AQQP
(EVENITY)
5. ANABOLIC AGENTS STIMULATES OSTEOBLAS-
TIC FORMATION
6. LIST OF ANABOLIC AGENTS -SCLEROSTIN INHIBITOR
-PARATHYROID HORMONE
-PARATHYROID HOR-
MONE-RELATED HOR-
MONE
7. SIDE EFFECTS OF RALOXIFENE (EVISTA) -DVT
-HOT FLASHES
-FLUID RETENTION
-CRAMPS
8. RALOXIFENE (EVISTA) -A NON-HORMONAL
AGENT THAT ACTS AS
ESTROGEN AGONIST ON
BONE BUT ACTS AS AN
, ARRT BONE DENSITOMETRY
Study online at https://quizlet.com/_dj82r4
ESTROGEN AGONIST ON
BREAST AND UTERUS
-REDUCES RISK OF INVA-
SIVE BREAST CANCER
9. LIST OF ESTROGEN AGONISTS/ANTAGO- RALOXIFENE (EVISTA)
NISTS
10. SIDE EFFECTS OF ESTROGEN (HORMONE -INCREASED RISK OF
THERAPY) BREAST CANCER
-HEART ATTACK
-STROKE
-DVT
11. ESTROGEN -FEMALE SEX HORMONE
-TAKEN DAILY IF USED
ORALLY
-TRANSDERMAL IS 2X
WEEKLY OR WEEKLY
12. SIDE EFFECTS OF DENOSUMAB (PROLIA) -HYPOCALCEMIA
-SKIN INFECTIONS
-OSTENECROSIS OF THE
JAW
13. DENOSUMAB (PROLIA) -PREVENTS DEVELOP-
MENT OF OSTEOCLASTS
-INJECTION EVERY 6
MONTHS
14. ZOLEDRONIC ACID (RECLAST) -INHIBITS OSTEOCLASTS
-GIVEN THROUGH IV
-CAN BE GIVEN YEARLY
OR ONCE EVERY 2 YRS
15. LIST OF IV BISPHOSPHONATES - IBANDRONATE (BONIVA)
- ZOLENDRONIC ACID (RE-
CLAST)
, ARRT BONE DENSITOMETRY
Study online at https://quizlet.com/_dj82r4
16. LIST OF ORAL BISPHOSPHONATES -ALENDRONATE (FOS-
AMAX AND BINOSTO)
-IBANDRONATE (BONIVA)
-RISENDRONATE (ATELVIA
AND ACTONEL)
17. LIST OF RANK LIGAND INHIBITORS (RANK DENOSUMAB (PROLIA)
L)
18. RANK LIGAND INHIBITOR (RANK L) -PREVENTS DEVELOP-
MENT OF OSTEOPOROSIS
-SHOWN TO INCREASE
BONE MINERAL DENSI-
TY AND DECREASE BONE
RESORPTION IN POST-
MENOPAUSAL WOMEN
19. RISENDRONATE (ACTONEL) -INHIBITS OSTEOCLASTS
-GIVEN ORALLY
-TAKEN WEEKLY
20. IBANDRONATE (BONIVA) -INHIBITS OSTEOCLASTS
-TAKEN MONTHLY IF ORAL
-GIVEN EVERY 3 MONTHS
IF IV
21. ALENDRONATE (BINOSTO) -INHIBITS OSTEOCLASTS
-TAKEN ORALLY
-TAKEN WEEKLY
-BISPHOSPHONATES
22. ALENDRONATE (FOSAMAX) -INHIBITS OSTEOCLASTS
-TAKEN ORALLY
-TAKEN DAILY /WEEKLY
23. LIST OF BISPHOSPHONATES 1. ALENDRONATE (FOS-
AMAX, BINOSTO)
2. IBANDRONATE (BONIVA)
3. RISENDRONATE (AC-